Among 23 plasma metabolomes that showed the same trends of alteration between HER2-positive and HER2-negative breast cancer patients, the changes in some of these metabolomes exhibited significant correlations with the changes in cardiac parameters only in HER2-positive or only in HER2-negative breast cancer patients, as detailed in Figs. 4, 5. This evidence concerns the gene ERBB2 and breast cancer.